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Novelty of the work 
In this work we performed the first transcriptional study of a filamentous fungus (N. 
crassa) in response to chitosan. 
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Abstract 24 
Chitosan is a natural polymer with antimicrobial activity. Chitosan causes plasma 25 
membrane permeabilization and induction of intracellular reactive oxygen species 26 
(ROS) in Neurospora crassa. We have determined the transcriptional profile of N. 27 
crassa to chitosan and identified the main gene targets involved in the cellular response 28 
to this compound. Global network analyses showed membrane, transport and 29 
oxidoreductase activity as key nodes affected by chitosan. Activation of oxidative 30 
metabolism indicates the importance of ROS and cell energy together with plasma 31 
membrane homeostasis in N. crassa response to chitosan. Deletion strain analysis of 32 
chitosan susceptibility pointed, NCU03639 encoding a class 3 lipase, involved in 33 
plasma membrane repair by lipid replacement and NCU04537 a MFS monosaccharide 34 
transporter related with assimilation of simple sugars, as main gene targets of chitosan. 35 
NCU10521, a glutathione S-transferase-4 involved in the generation of reducing power 36 
for scavenging intracellular ROS is also a determinant chitosan gene target. Ca2+ 37 
increased tolerance to chitosan in N. crassa. Growth of NCU10610 (fig 1 domain) and 38 
SYT1 (a synaptotagmin) deletion strains was significantly increased by Ca2+ in presence 39 
of chitosan. Both genes play a determinant role in N. crassa membrane homeostasis. 40 
Our results are of paramount importance for developing chitosan as antifungal. 41 
 42 
 43 
 44 
 45 
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Introduction 50 
Chitosan is a polymer obtained by partial chitin N-deacetylation1 which has antifungal 51 
activity.2 Chitosan inhibits growth of filamentous fungi and yeast human pathogens.3,4 52 
To develop chitosan as an antifungal treatment, a full understanding of its mode of 53 
action is necessary. In Saccharomyces cerevisiae, the response to chitooligosaccharides 54 
is mediated by proteins associated with plasma membrane, respiration, ATP production 55 
and mitochondrial organization.5 Five genes (arl1, bck2, erg24, msg5 and rba50) were 56 
characterized that provided chitosan resistance when overexpressed or increased 57 
sensitivity as a deletion strains. These genes have important roles in signaling pathways, 58 
cell membrane integrity and transcription regulation.5 Other transcriptional studies in S. 59 
cerevisiae revealed the relevance of oxidative respiration, mitochondrial biogenesis and 60 
transport in the response to chitosan.6 Previous physiological studies in N. crassa 61 
demonstrated that chitosan causes plasma membrane permeabilization.7 Membrane 62 
fluidity is a key factor determining chitosan sensitivity in fungi.8 Cell energy and 63 
mitochondrial activity have also an important role in moderating the antifungal activity 64 
of chitosan.7 The transcriptional response of filamentous fungi to this antifungal 65 
remains unknown. 66 
 67 
Membrane damage caused by currently used antifungals (eg. azoles) is associated 68 
with the induction of intracellular reactive oxygen species (ROS).9,10 We have recently 69 
shown that low chitosan concentration increased intracellular ROS levels in N. crassa 70 
leading to partial membrane permeabilization.4 Increasing chitosan dose dramatically 71 
raised ROS levels causing full membrane permeabilization and subsequent cell death. 72 
Oxidative stress by chitosan is mediated by the energetic status of the cell. A reduction 73 
in cell energy by blocking the electron transport chain protected N. crassa from chitosan 74 
damage.7 The plasma membrane of N. crassa contains high levels of polyunsaturated 75 
free fatty acids (FFA), this fact is directly associated with its susceptibility to chitosan.8 76 
Fungal plasma membrane lipids could be easily oxidized by an induction of intracellular 77 
oxidative stress generated by chitosan as found for other antifungals.10,11 This fact 78 
would link ROS and membrane homeostasis biology in the mode of action of chitosan. 79 
 80 
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Ca2+ is known to be involved in plasma membrane repair.12 Previous molecular 81 
studies revealed SYT1, a synaptotagmin, involved in membrane repair in several 82 
organisms13 including N. crassa.14 Moreover, Ca2+ plays a role in the response to 83 
oxidative stress and programmed cell death in N. crassa.15 PRM1 and FIG1 are key 84 
proteins in calcium-dependent plasma membrane remodeling during membrane fusion 85 
in S. cerevisiae and N. crassa.16-19 In N. crassa, two additional proteins, LFD1 and 86 
LFD2 are also involved in Ca2+-dependent plasma membrane repair during cell 87 
fusion.14,20 It is currently unknown, however, how fungi repair membrane damage 88 
caused by chitosan. 89 
 90 
In this work, we analyzed the transcriptional response of N. crassa germinating 91 
conidia and determined the main gene functions related with the exposure to chitosan. 92 
We applied temporal series analysis (Next-maSigPro21 and ASCA-genes22) and a 93 
network analysis approach (Cytoscape)23 to understand the dynamics of functions and 94 
gene targets involved in N. crassa response to chitosan. This study has pointed 95 
mitochondrion (ROS) and membrane homeostasis as the main functions in the response 96 
of N. crassa to chitosan and has identified key gene targets. Deletion strains of these 97 
key genes were evaluated for fitness and growth. We further demonstrated that 98 
extracellular calcium protects fungal cells from damage caused by chitosan. These 99 
studies are a key step for improving the knowledge on the mode of action of chitosan, 100 
which is essential for its future development as antifungal. 101 
Results and Discussion 102 
Chitosan causes an early activation and late repression of N. crassa genes  103 
The experimental conditions for analyzing the effect of chitosan on N. crassa 104 
germination and development are shown in Fig. 1. Time-course of N. crassa conidia 105 
germination is included in Figure 1A. Germination defects were quantified after 8h 106 
exposure of N. crassa conidia to 0.5 µg ml-1 chitosan (Fig. 1B; IC50) which showed an 107 
approximately 50% reduction in germination. This chitosan concentration was used for 108 
high throughput transcriptomic study. 109 
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To identify transcriptional changes caused by exposure of N. crassa to chitosan a 3-110 
stage time-course (4, 8 and 16h post-inoculation) was performed. A total of 523 N. 111 
crassa genes were considered differentially expressed (p-value < 0.05), with a fold 112 
change ≥ 2 (lower fold change values were considered non-significant), in response to 113 
chitosan (Fig. 2A). Of these, 55.6% (291 genes) were down-regulated and 45.3% (237 114 
genes) up-regulated. Our time-course experiment showed a progressive reduction in the 115 
number of genes whose expression increased upon exposure to chitosan (142 induced 116 
genes at 4h, 119 at 8h and 45 at 16h; Fig. 2B). In contrast, exposure to chitosan resulted 117 
in an increase in the number of genes whose expression levels decreased over time (79, 118 
93 and 207 genes down-regulated at 4, 8 and 16h, respectively; Fig. 2C). A subset of 22 119 
genes was differentially expressed consistently (p-value < 0.05; log2foldchange ≥ 2) 120 
throughout the whole time-course (Fig. 2A). Most of these genes (19) were down-121 
regulated, two genes were up-regulated and only one gene of this set (NCU05018) had 122 
an early (4 and 8h) induction and a late (16h) gene repression (Fig. 2D). 123 
Expression of 10 N. crassa genes representative of functional categories that were 124 
differentially expressed by exposure to chitosan were selected to validate our RNA-seq 125 
analysis. Gene expression was evaluated by qRT-PCR following an 8h exposure to 126 
chitosan (Fig S1). These genes were NCU05134, NCU06123, NCU07610, NCU01382 127 
and NCU05712 (involved in response to oxidative stress), NCU02363 (involved in 128 
response to chemical compounds), NCU05018, NCU3494 pin-c (related with 129 
heterokaryon incompatibility and membrane biology), NCU05764 (a sam-dependent 130 
methyltransferase) and a transcription factor with a zinc-finger domain (NCU05767). 131 
All genes analyzed by qRT-PCR showed an expression pattern consistent with that 132 
derived from RNA-seq data analysis (Fig. S1). 133 
N. crassa main gene functions differentially expressed with chitosan are 134 
oxidoreductase activity, membrane homeostasis and microtubule organization. 135 
A gene ontology (GO) functional annotation of N. crassa genes differentially expressed 136 
in response to chitosan was carried out using Blast2GO (Fig. 3 and Figs. S2 and S3). All 137 
GO-domains (molecular function, MF; biological process, BP; cell component, CC) and 138 
times were considered together for a complete functional gene expression analysis (Fig. 139 
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3A). Oxidoreductase activity (70 genes), membrane (57 genes) and transport (44 genes) 140 
were the most enriched GO-terms.  141 
Using maSigFun software for RNA-seq data time series analysis combined with GO 142 
annotation, we generated the time-course of functional gene expression for the most 143 
significantly enriched GO-terms representing N. crassa response to chitosan (Fig. 3B). 144 
The analysis identified 12 significant GO-terms using FDR=0.05 and R2=0.4 levels, as 145 
suggested in previous studies24. Chitosan modified patterns of expression of ROS-146 
related GO terms mitochondrion and peroxisome organization (Fig. 3B). Mitochondrion 147 
genes increased expression through time reaching maximum values of expression at 148 
16h, suggesting that chitosan enhances synthesis/turnover of mitochondrion components 149 
(respiration). Genes associated with peroxisome organization, involved in ROS 150 
degradation and catabolism of free fatty acids, were first highly expressed (4h) then 151 
completely repressed (16h).  Likewise, chitosan modified patterns of expression of GO 152 
categories related with membrane structure and biology. Exposure to chitosan was 153 
associated with repression at 16h of genes involved in cell cortex, vesicle organization 154 
and conjugation (Fig. 3B). Moreover, G-protein coupled receptor signaling were 155 
compromised by chitosan during all the time-course study (Fig. 3B). These features 156 
indicate that chitosan significantly compromised both structure and signaling associated 157 
with cell membrane homeostasis. Genes associated with GO-terms related to cell 158 
growth such as microtubule organizing center and motor activity had decreased 159 
expression values by chitosan through time (Fig. 3B). This behavior suggests the 160 
importance of cytoskeleton in the antifungal action of chitosan. Conversely, chitosan 161 
increased expression of genes associated with GO terms involved in protein synthesis 162 
(ribosome and ribosome biogenesis, Fig. 3B). This would support the increasing 163 
expression of genes and synthesis of proteins related to oxidoreductase activity by 164 
chitosan (Fig. 3A). In a similar way, nucleolus and structural molecule activity (Fig. 3B) 165 
genes were also late activated by chitosan. 166 
Potential gene targets of N. crassa to chitosan and their dynamics of expression  167 
Initial time-course analysis showed 5% of N. crassa genes significantly expressed in 168 
response of N. crassa to chitosan. A subset of 33 genes with a relevant change (p-value 169 
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< 0.05; log2fold-change > ±4.5) of expression is shown in Table S1. A restrictive cut-off 170 
was applied with the aim of detect the genes with large change in expression in response 171 
to chitosan. This subset included the 22 genes found in the differential gene expression 172 
analysis (Fig. 2) plus genes highly expressed (at early or late steps) associated with 173 
enriched GO-terms after chitosan exposure.  174 
When applying ASCA-genes method we focused on submodel (b+ab) that represents 175 
67.18% of total variation. Two components were selected, explaining 93% of this 176 
variability (52.38% and 40.62%, respectively; Fig. S4). They, therefore, represented the 177 
main gene expression in response to chitosan. First component identified a gene 178 
expression difference between chitosan and control constant through time (Fig. S4A). 179 
Second component identified expression pattern characterized by a clear interaction 180 
through time (Fig. S4B). The analysis of the squared prediction error (SPE) and 181 
leverage, determined a cut-off using gamma method, revealed 410 genes which 182 
followed the selected components (which explained 93% of variation) and 474 with a 183 
behaviour not identified in these (Fig. S5). Comparisons between ASCA and the fold-184 
change gene selection methods (523 genes in total) revealed 447 genes in common (Fig. 185 
S4C). Summarizes graphically this comparison where is observed a high overlap 186 
between fold-change gene selection and genes with high leverage (also scores can be 187 
observed). Moreover 33 genes with a relevant change (listed in Table S1) were also 188 
identified showing high scores for the two components identified after PCA (Fig.S4C).  189 
To inspect ASCA gene selection time series two cluster analyses were applied: one 190 
to the well-modelled genes (M) and another to the bad-modelled genes (NM) obtaining 191 
4 and 6 clusters respectively (Fig4 and S6). Both analyses were performed with the 192 
hierarchical method. Cluster 1M (Fig. 4A) contained genes associated with an early 193 
response to chitosan including two dioxygenases: NCU01849, the most highly 194 
expressed gene in response to chitosan (11.16 fold-induction) and NCU01071 a 195 
predicted 2OG-Fe dioxygenase, both involved in response to oxidative stress. 196 
We also found a set of genes mainly associated with plasma membrane, signaling 197 
and response to chemical compound (NCU02363; RTA1-like protein). In addition, a 198 
plasma membrane protein (het domain) associated with intracellular oxidative stress 199 
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(NCU07840), hypothetical protein with a C-terminal homeodomain (NCU00733) and 200 
hypothetical protein with a peroxisome membrane anchored protein conserved region 201 
(NCU04555) which strongly decreased in expression levels in N. crassa conidia treated 202 
with chitosan. Cluster 4M showed a steady increase of gene expression (Fig. 4D). 203 
Genes in this cluster were involved in cell response to oxidative stress (NCU05134 and 204 
NCU08907) and a monosaccharide transporter perhaps involved in chitosan 205 
assimilation or detoxification (NCU04537, fold-induction 9.27 after 16h growing with 206 
chitosan). Besides, other genes related with sugars assimilation were also induces in 207 
presence of chitosan such as NCU01633 (hxt13; Table S2). Clusters 2M and 3M, had 208 
gene expression changes in the control but not in the chitosan treatment (Figs. 4B and 209 
4C). Genes in these clusters were mainly related with fungal reproduction and 210 
development and response to oxidative stress. Cluster 2M included two genes 211 
associated with membrane homeostasis: NCU03494 (pin-c) essential for non-self-212 
recognition and NCU10610, a protein with a fig 1 domain (Ca2+ regulator and 213 
membrane fusion) related with cell fusion. 214 
Genes which did not fit the model (NM), with high SPE and leverage in the ASCA 215 
analysis, were grouped in 6 clusters including 474 genes (Fig. S6). Cluster 5NM which 216 
showed a late activation in presence of chitosan, included genes such as NCU10521 217 
(fold-induction 8.16 at 16h) a glutathione S-transferase-4 possibly involved in the 218 
generation of reducing power for scavenging intracellular ROS. Other genes involved in 219 
ROS assimilation were also induced at 16h such as NCU05780 (gst-1; Table S2). 220 
Cluster 3NM included expression of genes such as NCU08770 a hypothetical protein 221 
with a histone chaperone domain with slight changes of expression in presence of 222 
chitosan (Fig. S6). Cluster 4NM included genes with an early induction (4-8h) and then 223 
a reduction of gene expression such as NCU03639, a lipase class 3 involved in lipid, 224 
fatty acids and isoprenoid metabolism. The overexpression of this gene suggests its role 225 
in plasma membrane homeostasis during chitosan damage.  226 
Other significantly expressed (more than 6 fold-change expression, Table S2) genes 227 
in response to chitosan related with the main functions described previously included 228 
NCU03213 encoding a predicted mannosyl-phosphorylation protein related with 229 
phosphocholine metabolism (lipid modification). Early induction of other genes related 230 
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with predicted roles in lipid metabolism such as NCU16960 (geranyl reductase) putative 231 
involved in the biosynthesis of plasma membrane lipids were also detected.  232 
N. crassa deletion strains involved in membrane homeostasis and ROS 233 
detoxification showed increased sensitivity to chitosan 234 
Fifteen deletion strains of genes highly expressed and associated with enriched GO-235 
terms in response to chitosan were evaluated to identify gene targets in N. crassa. Five 236 
deletion strains showed increased sensitivity to chitosan (Fig. 5 and Fig. S7). 237 
∆NCU03639 (lipase) and ∆NCU04537 (monosaccharide transporter) were the most 238 
sensitive. These deletion strains exhibited a minimal inhibitory concentration (MIC, 3 239 
µg ml-1) lower than the WT (MIC 6 µg ml-1; Fig. 5A). They also showed a 6-8h delay in 240 
the start of the exponential growth phase at 2 µg ml-1 of chitosan in comparison to the 241 
WT (Figs. 5B-5D). Furthermore, ∆NCU10521 (glutathione S-transferase), ∆NCU08907 242 
Clock controller gene 13 (ccg-13) and ∆NCU07840 (plasma membrane protein with a 243 
het domain) were moderately (MIC at 4 µg ml-1) sensitive to chitosan (Fig. 5A). These 244 
strains showed a 6-12h delay in the start of exponential growth phase with respect to 245 
WT at 3 µg ml-1 of chitosan (Fig. S7). ∆NCU10610 (Ca2+ regulator with fig 1 domain) 246 
showed the same MIC as WT (6 µg ml-1), but had a delay (8h) in the start of exponential 247 
growth phase at 4 µg ml-1 chitosan (Fig. S7 and Table S3). Conversely, ∆NCU02363 248 
(RTA1 like-protein) and ∆NCU05134 (hypothetical protein) with the same MIC as the 249 
WT, started their exponential phases 7 and 16h earlier than WT (Fig. S7 and Table S3) 250 
indicating moderate tolerance of chitosan respect to WT. ∆NCU08770 (hypothetical 251 
protein with a histone chaperone domain CHZ) had increased resistance to chitosan 252 
(MIC > 6 µg ml-1; Fig. 5E). The start of the exponential growth phase in this deletion 253 
strain was 15h earlier than WT at 4 µg ml-1 of chitosan (Table S3). 254 
Thirteen deletion strains (mating type a) were crossed to WT (mating type A) to 255 
assess meiotic segregation of chitosan sensitivity phenotype with the hygromycin 256 
marker. Seggregants of each mutant showed similar chitosan sensitivity than the 257 
original deletion strain. In four chitosan gene targets (∆NCU03639, ∆NCU04537, 258 
∆NCU07840 and ∆NCU10521), segreggants showed the same chitosan antifungal 259 
phenotype (MIC) and hygromycin resistance than the original deletion strains. 260 
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Ca
2+
 protects N. crassa conidia from chitosan damage  261 
Ca2+ increased tolerance to chitosan in N. crassa (Fig. 6). The WT strain at 0.68 mM 262 
CaCl2
 with 0.5 µg ml-1 chitosan resumed growth 4h earlier than without Ca2+ (Figs. 6A). 263 
A higher level of CaCl2 (2.72 mM) in the presence of 0.5 µg ml
-1 chitosan further 264 
improved fungal growth with a 7h advance in the start of the exponential phase with 265 
respect to N. crassa with chitosan and no calcium (Fig. 6A). Increasing CaCl2 266 
concentrations with no chitosan did not affect fungal growth (data not shown). 267 
Conidia in calcium-free medium treated with chitosan (0.5 µg ml-1) were stained 268 
(Fig. 6B) with the vital dye propidium iodide (PI) indicating cell mortality. On the 269 
contrary, conidia treated with both chitosan (0.5 µg ml-1) and calcium chloride (0.68 270 
mM), this showed no staining remaining alive (Fig. 6C). Similar results were found 271 
when increasing chitosan concentrations (Fig. S8). In particular, 0.5, 2.5 and 5 µg ml-1 272 
chitosan and CaCl2 treated cells had significantly (p-value < 0.05) lower mortality than 273 
conidia treated with chitosan but no calcium. 274 
Treatment with Ca2+ also reduced chitosan damage in deletion strain in the locus 275 
∆NCU10610 with a fig 1 domain and ∆NCU03263 (syt-1), both associated with plasma 276 
membrane remodeling (Figs. 6D and 6E). Increasing CaCl2 concentration (10 mM to 20 277 
mM) significantly improved growth of WT, ∆NCU10610 and ∆NCU03263 strains in a 278 
medium amended with a high amount of chitosan (4 µg ml-1; Figs. 6D and 6E). With 279 
less concentration of Ca2+ in the medium (0.68 mM), chitosan completely inhibited 280 
fungal growth. ∆NCU10610 showed more tolerance to chitosan respect to WT, this 281 
strain started exponential phase at 27h, whereas WT strain did so 3h later under the 282 
same conditions. ∆NCU03263 was most sensitive to chitosan with high amount of 283 
calcium, starting the exponential phase after 35h, with slower growth than WT and 284 
∆NCU10610. When [CaCl2] was increased (20 mM) all strains tested showed higher 285 
resistance to chitosan (Fig. 6E). This was especially relevant for ∆NCU03263 which 286 
showed a ca. 2 fold growth increase under these conditions (Fig. 6E). 287 
 288 
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We found in this work that chitosan significantly induced changes of expression of 289 
5% of N. crassa genes in the genome. A global Cytoscape network showed membrane 290 
and transport as key nodes grouping genes affected by chitosan (Fig. 7). Plasma 291 
membrane was connected with cell vesicles and cell wall suggesting the importance of 292 
these outer structures and their dynamics in presence of chitosan. Oxidoreductase 293 
enhanced node indicated the importance of ROS and cell energy in N. crassa response 294 
to chitosan.4,7 Several nodes related with cytoskeleton dynamics indicate that chitosan 295 
also affects cell growth (Fig. 7).  Other transcriptional studies, using S. cerevisiae 296 
mutant collections determined genes associated with plasma membrane, respiration, 297 
ATP production and mitochondrial organization as main targets of 298 
chitooligosaccharides.5,6  299 
In this study, we demonstrated that exposure to chitosan increased the expression of 300 
genes involved in plasma membrane dynamics such as lipases. Imidazoles and triazoles 301 
(e.g. fluconazole, voriconazol and others) mode of action is based on the ergosterol 302 
biosynthesis inhibition,25,26 thereby altering plasma membrane fluidity. Chitosan is also 303 
an antifungal affecting plasma membrane. Fungi with enriched unsaturated free fatty 304 
acids in their plasma membrane (increased fluidity) are sensitive to chitosan (e.g. N. 305 
crassa). In contrast, fungi with less unsaturated free fatty acids in their membranes (low 306 
fluidity) such as the nematophagus fungus Pochonia chlamydosporia, are resistant to 307 
chitosan.8,27 In our work, we show that chitosan activates genes related with plasma 308 
membrane homeostasis such as the class 3 lipase NCU03639 (Fig. 8). The increase on 309 
chitosan sensitivity of NCU03639 deletion strain and the induction of genes related with 310 
free fatty acid plasma membrane remodeling such as NCU16960 (geranyl reductase), 311 
suggests their role in lipid replacement. This group of genes is mainly associated with 312 
plasma membrane stabilization by changes in free fatty acid composition caused by 313 
other abiotic stresses.28 Furthermore, chitosan also activated genes related with vesicular 314 
transport, which is associated with lipid transfer.29 315 
Moreover, chitosan also induced expression of N. crassa genes related with 316 
movement of molecules through plasma membrane such as MFS transporters. The 317 
activation of a monosaccharide transporter and other genes related with exchange of 318 
molecules is one of the general responses of N. crassa to chitosan. Transport activation 319 
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is a widely described response of several filamentous fungi and yeast in response to 320 
antifungals.30 C. albicans activates genes involved in transport and molecule trafficking 321 
in presence of ketoconazole.31 Susceptibility to azoles has been likely found due to a 322 
reduced efflux activity of pumps.32 Likewise, amphotericin B induces expression of 323 
high-affinity glucose transporters (MFS transporters) and permeases encoding genes in 324 
S. cerevisiae.30 In our study, N. crassa NCU04537 deletion strain, encoding a 325 
monosaccharide transporter, showed an increase in chitosan sensitivity, suggesting a 326 
determinant role of this protein in the assimilation of glucosamine and N-acetyl 327 
glucosamine monomers.33 328 
Currently used antifungals, as well as chitosan, induce intracellular oxidative stress 329 
affecting plasma membrane permeability. This may be associated with an imbalance of 330 
intracellular redox state.4,10 An increase in the intracellular ROS is a general response to 331 
several antifungals and antimicrobial peptides which target the plasma membrane.9,34 332 
We have also recently demonstrated that chitosan elicited a rise in ROS coincident with 333 
the start of plasma membrane permeabilization.4 In this paper we have demonstrated 334 
that chitosan induced the expression of genes encoding mono- and dioxygenases and 335 
other proteins related with ROS homeostasis. Other antifungals (e.g. rotenone and 336 
staurosporine) also increase levels of intracellular oxidative stress associated with 337 
subsequent cellular death.35,36 Increase in associated ROS by chitosan could induce 338 
plasma membrane free fatty acid oxidation and formation of oxylipins.37 These would 339 
damage plasma membrane and cause its subsequent permeabilization.38 In our study, 340 
when NCU10521, encoding a glutathione S-transferase (GST), was eliminated 341 
sensitivity of N. crassa to chitosan increased. GST is known to deaden ROS by-342 
products such as peroxidized lipids.39 This suggests a link between ROS and membrane 343 
damage in the mode of action of chitosan (Fig. 8). Other antifungals also induce 344 
glutathione enzymes to reduce intracellular ROS levels in N. crassa.40 345 
We have discovered that chitosan inhibits gene functions related with cytoskeleton 346 
dynamics such as microtubule organization and motor activity. Increased levels of 347 
intracellular ROS in Magnaporthe oryzae caused F-actin depolymerization affecting 348 
hyphal polar growth.41 In N. crassa deletion of a NOX gene encoding a NADPH 349 
oxidase results in reduction of hyphal growth.42 These observations support the 350 
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hypothesis that an increase in intracellular ROS causes an abnormal distribution of F-351 
actin. Cytoskeleton disorganization could then be one of the mechanisms by which 352 
chitosan inhibits fungal growth. The oxidative stress and associated phenomena such as 353 
free fatty acid peroxidation or F-actin polymerization could be directly involved in 354 
chitosan antifungal activity. 355 
It is known that the balance between Ca2+ and ROS affects intracellular signaling and 356 
cell homeostasis.43 We have demonstrated that Ca2+ is involved in N. crassa tolerance to 357 
chitosan. Ca2+ is also involved in the increasing threshold of N. crassa to antifungals 358 
such as staurosporine.44 Calcium plays a role in the mechanisms of plasma membrane 359 
remodeling in S. cerevisiae budding45 and during cell fusion in N. crassa.14,17 In this 360 
work, we report NCU10610 (Ca2+ regulator with fig 1 domain) significantly repressed 361 
by chitosan. The presence of a fig 1 domain suggests its role as Ca2+ regulator in cell 362 
fusion. In view of the relevance of this phenomenon in plasma membrane remodeling, 363 
we have also evaluated the role of SYT1 in the mechanisms of plasma membrane 364 
remodeling mediated by Ca2+. SYT1 may be involved in membrane damage restored 365 
during fusion of germlings in N. crassa.14 In our study ∆syt1 had increased sensitivity to 366 
chitosan. When ∆syt1 was exposed to chitosan together with Ca2+ (10 mM) we found 367 
increased sensitivity of this deletion strain to chitosan respect to WT. This would be 368 
associated with the capability of this gene to trigger mechanisms of plasma membrane 369 
damage repair mediated by Ca2+. Besides, high levels of extracellular Ca2+ (20 mM), 370 
highly reduced chitosan damage in ∆syt1. This deletion strain grow with the same 371 
fitness that the WT under these conditions. This would be associated with the activation 372 
of other N. crassa genes involved in plasma membrane remodeling mediated by Ca2+. 373 
Our results would suggest the importance of Ca2+ on the mechanisms of plasma 374 
membrane remodeling after chitosan damages. 375 
Conclusion and outlook 376 
This work provides the first study of the gene expression response of a filamentous 377 
fungus (N. crassa) to chitosan. Transcriptomics revealed oxidoreductase activity, 378 
membrane homeostasis and microtubule organization as the main gene functions 379 
differentially expressed. We identified a class 3 lipase, a MFS monosaccharide 380 
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transporter and a glutathione transferase as main gene targets of chitosan in N. crassa. 381 
Our study opens new possibilities to study gene pathways involved in membrane 382 
remodeling after chitosan damage with a relevant role of Ca2+. These studies are a key 383 
step to develop chitosan as antifungal drug in the future. Our results could help to 384 
identify the main gene targets of chitosan in medical important fungi. 385 
Methods 386 
Growth conditions  387 
Neurospora crassa wild-type strain was 74-OR23-IVA (FGSC2489) and the deletion 388 
strains were generated by the Neurospora Genome Project46,47 and kindly provided by 389 
the Fungal Genetics Stock Center (FGSC, Kansas, USA)48 are shown in Table S1. 390 
Strains were grown on Vogel’s minimal medium agar (VMMA) (1x Vogel’s salts, 2% 391 
sucrose and 1.5% technical agar).  392 
Chitosan 393 
 A medium molecular weight chitosan (70 kDa) with an 82.5% deacetylation degree 394 
(T8s; Marine BioProducts GmbH; Bremerhaven, Germany) was used. Chitosan was 395 
prepared as described in Palma-Guerrero et al., 2008.27 396 
Germinating conditions and time-course of N. crassa sensitivity to chitosan 397 
To determine the optimal medium to assess the behavior of N. crassa exposed to 398 
chitosan, three variants of the Vogel’s minimal medium were evaluated (VMM). These 399 
media were standard VMM (1x salts, 2% sucrose), VMM salts diluted 100 times with 400 
2% sucrose and VMM salts diluted 100 times and 0.02% sucrose. We finally adopted 401 
the second one because chitosan precipitated with some salts included in standard 402 
VMM. Time-course experiments of germination were assessed every 2h for 24h under 403 
continuous light, shaking at 200 rpm and 25ºC. 404 
N. crassa conidia sensitivity to chitosan was evaluated using selected media, with 405 
sub-lethal concentrations of chitosan (0.1-1 µg ml-1). The percentage of N. crassa 406 
conidial germination with chitosan for 2, 4, 6, 8, 10, 12 and 16h after inoculation was 407 
Page 15 of 36 Molecular BioSystems
M
ol
ec
ul
ar
B
io
S
ys
te
m
s
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
01
 D
ec
em
be
r 2
01
5.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
id
ad
 d
e A
lic
an
te
 o
n 
09
/1
2/
20
15
 1
5:
48
:5
4.
 
View Article Online
DOI: 10.1039/C5MB00649J
15 
 
 
measured. We selected a chitosan dose that resulted in a 50% inhibition of germination 408 
respect to the control (IC50).  409 
RNA extraction and cDNA synthesis. 410 
From N.  crassa cultures in contact with chitosan and controls (without chitosan) for 4, 411 
8 and 16h total RNA was isolated using TRIzol reagent (Life Tech) according to the 412 
manufacturer’s instructions. RNA was then treated with DNase (Turbo DNA-free, 413 
Ambion) to eliminate DNA remains. For poly (A+) RNA purification, 10 µg of total 414 
RNA was bound to dynal oligo (dT) magnetic beads (Invitrogen) twice, using the 415 
manufacturer's instructions.  Purified poly (A+) RNA was fragmented by metal-ion 416 
catalysis (Ambion) followed by precipitation with 1/10 vol 3M sodium acetate and 3× 417 
vol 100% ethanol. Precipitated RNA was 70% ethanol washed and then resuspended 418 
into 10.5 µl nuclease free water.  For first strand cDNA synthesis, the fragmented poly 419 
(A+) RNA was incubated with 3 µg random hexamers (Invitrogen), incubated at 65°C 420 
for 5 min and then transferred to ice. First strand buffer (4 µL; Invitrogen), 421 
Dithiothreitol (DTT), dNTPs and RNAseOUT (Invitrogen) were added to a final 422 
concentration of 1×, 10 mM, 200 µM and 1U/µL, respectively in a final volume of 20 µl 423 
and the samples were incubated at 25°C for 2 minutes.  Superscript II (200 U; 424 
Invitrogen) were added and the samples were incubated at 25°C for 10 min, 42°C for 50 425 
min and 70°C for 15 min.   For second strand synthesis, 51 µL of H2O, 20 µL of 5× 426 
second strand buffer (Invitrogen), and dNTPs (10 mM) were added to the first cDNA 427 
strand synthesis mix and incubated on ice for 5 min. RNaseH (2 U; Invitrogen), DNA 428 
pol I (50 U; Invitrogen) were then added and the mixture was incubated at 16°C for 429 
2.5h. 430 
Library construction and sequencing 431 
End-repair was performed by adding 45 µL of H2O, T4 DNA ligase buffer with 10 mM 432 
ATP (NEB; 10 µL), dNTP mix (10 mM), T4 DNA polymerase (15 U; NEB), Klenow 433 
DNA polymerase (5 U; NEB), and T4 PNK (50 U; NEB) to the sample and incubating 434 
for 30 min at 20°C. A single base was added each to cDNA fragment by adding Klenow 435 
buffer (NEB), dATP (1 mM), and Klenow 3′ to 5′ exo- (15 U; NEB).  The mixture was 436 
then incubated at 37°C for 30 min. Standard Illumina adapters (FC) were ligated to the 437 
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cDNA fragments using 2× DNA ligase buffer (Enzymatics), 1 µL of adapter oligo mix 438 
and DNA ligase (5 U; Enzymatics). The sample was incubated at 25°C for 15 min.  The 439 
sample was purified in a 2% low-melting point agarose gel, and a slice of gel containing 440 
200-bp fragments was removed and the DNA purified. The polymerase chain reaction 441 
(PCR) was used to enrich the sequencing library. A 10 µL aliquot of purified cDNA 442 
library was amplified by PCR using the pfx DNA polymerase (2 U; Invitrogen) and 443 
with 1 µl of genomic primers 1.1 and 2.1 (Illumina).  PCR cycling conditions included a 444 
denaturing step at 98°C for 30 sec, 12 cycles of 98°C for 10 sec, 65°C for 30 sec, 68°C 445 
for 30 sec, and a final extension at 68°C for 5 min.  All libraries were sequenced on a 446 
HiSeq 2000 platform to a depth of over 190 million 50 bp reads using standard Illumina 447 
operating procedures. 448 
Transcript abundance, annotation and functional analysis. 449 
Sequenced libraries were mapped against predicted transcripts from the Neurospora 450 
crassa OR74A genome (v10) with TopHat (v2.0.4)49 and the short sequence aligner 451 
Bowtie (v2.0.0.6).50 Transcript abundance measured as FPKMs (Fragments Per 452 
Kilobase transcript model per Million fragments mapped) was calculated with Cufflinks 453 
(v 2.0.2) using counts that exclusively mapped to predicted transcripts to estimate the 454 
FPKM denominator. Genes which had a differential expression cut-off of p-value < 455 
0.05 (we adjusted p-value as the Benjamini Hochberg filter; q value in TopHat; to adjust 456 
for the false discovery rate) between control and sample were used for further analysis. 457 
In the fold change analysis a lo2foldchange ≥ 2 was adopted to characterize the main 458 
gene functions and genes involved in the response of N. crassa to chitosan. The project 459 
of N. crassa gene expression profile in response to chitosan has been deposited in 460 
NCBI’s Gene Expression Omnibus51 and is accessible through GEO Series accession 461 
number GSE75293 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE75293). 462 
N. crassa transcript sequences were re-annotated using Blast2GO software (Version 463 
2.7.1) to improve the standard annotation provided by the Broad N. crassa genome 464 
(http://www.broadinstitute.org/annotation/genome/neurospora/MultiHome.html), a 465 
consensus set of transcripts were functionally annotated (gene ontology, GO) using 466 
Blast2GO (http://www.blast2go.com/b2ghome).52 Gene families were established using 467 
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the InterPro (http://www.ebi.ac.uk/interpro) and KEGG databases 468 
(http://www.genome.jp/kegg/pathway.html). For N. crassa gene annotation we also 469 
used several tools, HMMR53 including Pfam, TIGRFAM, Gene 3D and Superfamily 470 
databases. In addition, Wolf PSORT54 was used to obtain information about domains 471 
and cellular gene localizations. Gene annotations were finally examined using 472 
BLASTp.55 473 
RNA-seq time-series data analysis 474 
Significant differential gene expression changes over time were assessed by applying 475 
the maSigPro R package21 to the groups of genes included in each functional GO 476 
category. This approach was described, as an adaptation of maSigPro56 named 477 
maSigFun24 for microarray data. This algorithm has been updated for RNA-seq data in 478 
this work. The maSigPro method follows a two-stage regression strategy to identify 479 
genes with significant changes in expression over time. False discovery rate (FDR) and 480 
R2 level as measure of the good of fit of the regression model are the factors for gene 481 
selection. Finally the package includes several clustering algorithms and visualization 482 
tools available to group and display the selected gene-profiles.  483 
Transcriptional responses of interest were detected with the application of ASCA-484 
genes method.22 Considering an experiment with 2 factors (a and b, usually time and the 485 
experimental group, in our case chitosan treatment), data can be collected in a data 486 
matrix X, where rows represent samples and columns represent genes. ASCA first 487 
decomposes X into matrices (Xa, Xb and Xab) with the estimates of the ANOVA 488 
(Analysis of Variance) parameters: Xa contains the time effects, Xb treatment effects 489 
and Xab the interactions, obtained gene by gene. When the main interest of a study is the 490 
identification of genes with differences in the experimental groups, Xb is joined to Xab. 491 
Principal Component Analysis (PCA) is then applied on each of these matrices to 492 
summarize the information of each source of variation and giving as a result two PCA 493 
analyses that are called submodels. ASCA-genes compute the main patterns of variation 494 
and two statistics for each gene in each submodel: leverage and the squared-prediction 495 
error (SPE). Leverage indicates the importance of a gene in the main behavior 496 
discovered. SPE quantifies the variability of a gene that is not detected for the model. 497 
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Focusing on these measures, ASCA-genes provides two lists of genes: the first one with 498 
genes that follow the main general patterns. The second one including genes with odd 499 
behaviors or outlier data. To obtain this gene selection the gamma method57 was 500 
applied.  501 
Real time quantitative PCR for RNA-seq validation 502 
cDNA was synthetized with a retro-transcriptase RevertAid (Thermo) using oligo dT 503 
(Thermo). Gene expression was quantify using real-time reverse transcription PCR 504 
(qRT-PCR), SYBR Green with ROX (Roche) were used following the manufacturer’s 505 
instructions. Gene quantifications were performed in a Step One Plus real-time PCR 506 
system (Applied Biosystems). Relative gene expression was estimated with the ∆∆Ct 507 
methodology,58 with three technical replicates per condition. Primers used to quantify 508 
the expression of genes related with N. crassa response to chitosan are shown in Table 509 
S4. Expression of the TATA-binding protein (NCU04770) and transcription elongation 510 
factor S-II (NCU02563) were used as endogenous controls for all experiments, since 511 
these genes showed Ct stability for all conditions tested.  512 
Evaluation of selected deletion strains to determine the genes involved in the 513 
response of N. crassa to chitosan 514 
Experiments in liquid media were set to evaluate growth kinetics of N. crassa (WT) and 515 
selected homokaryons deletion strains (Table S1). N. crassa conidia were obtained from 516 
8-10 day-old sporulated cultures, by adding 2 ml of distilled water. The resulting 517 
conidial suspensions were then filtered through Miracloth (Calbiochem) to remove 518 
hyphal fragments. Conidial suspensions were adjusted to a final concentration of 106 519 
conidia ml-1 with 1/100 VMM salts and 2% sucrose. 520 
Chitosan (1-6 µg ml-1) was added to the medium and 200 µL per well were dispensed 521 
into 96 well microtiter plates (Sterillin Ltd., Newport, UK). Plates were inoculated with 522 
N. crassa conidia (2×105 conidia per well) and then incubated at 25 ºC during 48h in a 523 
GENiosTM multiwell spectrophotometer (Tecan, Männedorf, Switzerland) in the dark. 524 
The chitosan effect on growth of N. crassa strains was evaluated by measuring optical 525 
density at 490 nm (OD490).
4 In order to identify the antifungal activity of chitosan on N. 526 
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crassa strains, we applied a spot assay in SFG medium (2% sorbose, 0.05% glucose and 527 
fructose and 1.5% agar).59  528 
Growth in presence of the same concentration of deletion strains (mating type a) to 529 
chitosan was confirmed by segregation analysis.60 Ascospore progeny were selected 530 
from crosses with FGSC 2489 (mating type A). Seggregants were tested both for 531 
chitosan and hygromycin sensitivity. The latter was tested in all deletion strains used in 532 
this work. Seggregants had the same chitosan sensitivity than the original deletion strain 533 
and were hygromycin (200 µg ml-1) resistant.  534 
Evaluation of the effect of Ca
2+
 in the response of N. crassa to chitosan  535 
To evaluate the effect of Ca2+ on conidia treated with chitosan, we exposed N. crassa 536 
conidia (106 conidia ml-1) to chitosan (0.5 µg ml-1) with either 0.17; 0.34; 0.68; 1.36 or 537 
2.72 mM CaCl2. Growth kinetics was evaluated in a 96-multiwell microplate by 538 
measuring optical density at 490 nm for 48h, as described above. 539 
Viability of conidia was determined using propidium iodide (PI; Sigma)7 after 540 
exposure to chitosan (0.5 µg ml-1), and CaCl2 at 0.68 mM, conidia without CaCl2 were 541 
used as a controls for this compound. N. crassa conidia were treated with chitosan for 2 542 
h and then labeled with 2 µg ml-1 PI to evaluate cell viability. Fluorescence in conidia 543 
was assessed using an Olympus BH-2 fluorescence microscope with 488 nm and 560 544 
nm as excitation and detection wavelengths, respectively, and then photographed with a 545 
Leica DFC480 digital camera (Leica Microsystems, Wetzlar, Germany).  546 
The effect of higher concentrations of Ca2+ (10 and 20 mM) on WT and two deletion 547 
strains, ∆NCU10610 (Ca2+ regulator with fig 1 domain) and ∆NCU03263 (syt1) when 548 
combined with chitosan (4 µg ml-1) was also determined.  549 
Cytoscape network of functional gene annotation of N. crassa gene response to 550 
chitosan  551 
For this analysis, we performed functional enrichment analysis with GSEA (Gene Set 552 
Enrichment Analysis).61 The enrichment maps were generated with Enrichment Map 553 
Plugin v1.162 developed for Cytoscape.23 Nodes in the maps were clustered with the 554 
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Markov clustering algorithm, using an overlap coefficient computed by the plugin as the 555 
similarity metric (coefficient < 0.5 were set to zero) and an inflation parameter with 556 
value of 2. For each cluster, the leading edge was computed as in Subramanian et al. 557 
(2005)61 for each member of a node. A complete functional gene network map of N. 558 
crassa in response to chitosan was finally generated. 559 
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Figure legends 687 
Figure 1. Time-course effect of chitosan on N. crassa conidia germination. (A) 688 
N. crassa germination started prior to 4h then conidia develop a germ tube (6-8h) and 689 
established a young mycelium before 16h. (B) Effect of chitosan on conidia germination 690 
at 8h, IC50 (50% germination) was found at 0.5 µg ml
-1 chitosan. IC50: half maximal 691 
inhibitory concentration. 692 
Figure 2. Venn diagram of differential gene expression of N. crassa in response 693 
to chitosan. (A) Complete differential gene expression (DGE) including induced and 694 
repressed genes in the 4-16h time-course. (B) Increased DGE, up-regulated genes. (C) 695 
Decreased DGE, down-regulated genes. (D) Fold-change of 22 genes significantly 696 
differentially expressed in response to chitosan during the whole time-course 697 
expermient. 698 
Figure 3. Gene Ontology (GO) functional annotation of N. crassa genes 699 
differentially expressed in response to chitosan. (A) Global GO annotation of 700 
significantly expressed genes. (B) Selected GO-terms time-series with maSigFun 701 
represented as the average expression profile of the associated genes to each GO.  702 
Figure 4. (A-D) Time-series analysis of genes associated with the response of N. 703 
crassa to chitosan by ASCA-genes. Graphs represent gene expression average trend of 704 
four clusters of genes that follow the discovered general patterns of the ASCA model. 705 
Genes that are well represented by the PC obtained with the ASCA model. 706 
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Figure 5.  Effect of chitosan on growth of N. crassa WT and selected deletion 707 
strains from RNAseq data. (A) Chitosan minimal inhibitory concentration (MIC) of 708 
selected deletion strains and WT. (B-E) Fungal growth kinetics of (B) WT, (C) 709 
∆NCU03639, (D) ∆NCU04537 and (E) ∆NCU08770 in response to increasing 710 
concentrations of chitosan (n=4; mean ± SE).  711 
Figure 6. Effect of Ca2+ on chitosan antifungal activity to N. crassa WT and 712 
deletion strains from membrane remodeling genes (∆NCU10610 and ∆NCU03263-∆ 713 
syt 1). (A) N. crassa WT growth in response to chitosan (0.5 µg ml-1) under several 714 
Ca2+ concentrations. (B) Nuclear damage after treatment of conidia of a strain in which 715 
PI has been targeted to the nuclei. Conidia treated with chitosan and stained with 2 µg 716 
ml-1 propidium iodide (PI). Fluorescence images right and DIC images of same conidia 717 
on the left. Bar = 5 µm. (C) Evaluation of conidia viability treated with chitosan and 718 
Ca2+ stained with PI.  719 
Figure 7. Cytoscape network of functional gene annotation of N. crassa gene 720 
response to chitosan. Large font tittles represents a summary of GO-terms found 721 
enriched in clusters. Node size correlates to the number of genes annotated to that 722 
functional category. Each node represents a gene function significantly enriched (FDR≤ 723 
0.1). 724 
Figure 8. Key genes associated with N. crassa response to chitosan. In this 725 
model, NCU03639 would increase membrane permeability by altering mechanisms of 726 
plasma membrane remodeling and fluidity. NCU10610 (Ca2+ regulator with fig 1 727 
domain) would be associated with the mechanisms of plasma membrane remodeling 728 
mediated by Ca2+. NCU04534 (MFS transporter) could be involved in mechanisms of 729 
assimilation or detoxification monosaccharaides (e.g. monomers of N-acetyl 730 
glucosamine). NCU10521 (glutathione transferase), NCU01849 and NCU01071 731 
(dioxygenases) would be related with the response of the fungus to the oxidative stress, 732 
the key response of N. crassa to chitosan. Genes involved in mechanisms associated 733 
with protein synthesis (NCU04555) and resistance to chemical compounds 734 
(NCU02363) are also differentially expressed in response to chitosan.  735 
 736 
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